Skip to main content

Stiripentol News

Antiseizure Drug Diacomit Now Approved for Children as Young as 6 Months

SAN MATEO, Calif., Sept. 21, 2022 /PRNewswire/ – Biocodex, Inc., a pharmaceutical company and manufacturer of Diacomit® (stiripentol), announced today that the U.S. Food and Drug Administration (...

FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome

On August 20, 2018, the U.S. Food and Drug Administration (FDA) approved Diacomit (stiripentol) for seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam. ...

FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome

On August 20, 2018, the U.S. Food and Drug Administration (FDA) approved Diacomit (stiripentol) for seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam. ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Stiripentol patient information at Drugs.com